ClinicaliQ Trial Snapshot
- Feasibility of Novel Clinical Trial Infrastructure, Design and Technology for Early Phase Studies in Patients With Pulmonary Hypertension (FIT-PH) — Recruiting • Cardiology / Cardiovascular • NCT04078243.
- What is being tested: Novel implantable pulmonary artery pressure (PAP) monitors and wearable activity monitoring devices to assess their safety, feasibility, and utility for remote patient management in pulmonary hypertension.
- Patient eligibility overview: Adults with established pulmonary hypertension diagnosis who can tolerate device implantation and use wearable technology; specific eligibility criteria determined by individual PH phenotype and haemodynamic status.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
Prospective, open-label, observational study to evaluate the safety and feasibility of using pulmonary artery pressure (PAP) monitors and wearable activity monitors in patients with pulmonary hypertension (PH).
Eligibility Snapshot
- : * Diagnosis of pulmonary hypertension (Group I,II,III and IV) * Age 18 years * Estimated glomerular filtration rate (eGFR) > 25 * Body mass index (BMI) < 35 (or equivalent) * Pulmonary artery (PA) branch 7mm * Negative pregnancy test (If female of childbearing age) * Written, informed consent completed * Willingness of the patient to comply
Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.